Study on 2 booster candidates to anticipate omicron-like mutations: Moderna

Published on : 11:09 AM Nov 27, 2021

US-based pharmaceutical company Moderna stated on Friday that it is studying two booster shot candidates in order to check mutations similar to the newly found Omicron variant of COVID-19.

Washington: US-based pharmaceutical company is studying two booster candidates designed to anticipate mutations similar to the Omicron COVID-19 variant.

Advertisement

window.googletag = window.googletag || {cmd: []}; googletag.cmd.push(function() {var userAgent = window.navigator.userAgent.toLowerCase();var Andrioid_App = /webview|wv/.test(userAgent);var Android_Msite = /Android|webOS|BlackBerry|IEMobile|Opera Mini/i.test(navigator.userAgent);var iosphone = /iPhone|iPad|iPod/i.test(navigator.userAgent);var is_iOS_Mobile = /(iPhone|iPod|iPad).*applewebkit(?!.*version)/i.test(navigator.userAgent); if ( Andrioid_App == true || iosphone == true ) {console.log("Mobile"); var slot_9722 = googletag.defineSlot("/175434344/ETB-APP-ADP-English-National-International-300x250-1", [300, 250], "div-gpt-ad-7177448951973-0").addService(googletag.pubads());}else if(Android_Msite == true || is_iOS_Mobile == true){console.log("m site"); var slot_9722 = googletag.defineSlot("/175434344/ETB-MDOT-ADP-English-National-International-300x250-1", [300, 250], "div-gpt-ad-7177448951973-0").addService(googletag.pubads());}else{console.log("Web"); var slot_9722=googletag.defineSlot("/175434344/ETB-ADP-English-National-International-728x90-1", [728, 90], "div-gpt-ad-7177448951973-0").addService(googletag.pubads());} googletag.pubads().enableSingleRequest();googletag.pubads().collapseEmptyDivs();googletag.enableServices(); googletag.display("div-gpt-ad-7177448951973-0");googletag.pubads().refresh([slot_9722]);googletag.pubads().setCentering(true); });
googletag.cmd.push(function() { googletag.display("div-gpt-ad-7177448951973-0");googletag.pubads().refresh(); });

On Friday, the US-based pharmaceutical company Moderna stated that it is examining two booster shots candidates. The examination is being done to check mutations similar to the Omicron COVID-19 variant, reported Sputnik.

The Omicron COVID-19 variant was found first in South Africa this week. Advertisement

Also read: COVID-19 vaccine boosters could mean billions for drugmakers

Sputnik quoted Moderna as saying, "Moderna is already studying two multi-valent booster candidates in the clinic that were designed to anticipate mutations such as those that have emerged in the Omicron variant."

window.googletag = window.googletag || {cmd: []}; googletag.cmd.push(function() {var userAgent = window.navigator.userAgent.toLowerCase();var Andrioid_App = /webview|wv/.test(userAgent);var Android_Msite = /Android|webOS|BlackBerry|IEMobile|Opera Mini/i.test(navigator.userAgent);var iosphone = /iPhone|iPad|iPod/i.test(navigator.userAgent);var is_iOS_Mobile = /(iPhone|iPod|iPad).*applewebkit(?!.*version)/i.test(navigator.userAgent); if ( Andrioid_App == true || iosphone == true ) {console.log("Mobile"); var slot_9601 = googletag.defineSlot("/175434344/ETB-APP-ADP-English-National-International-300x250-1", [300, 250], "div-gpt-ad-9328143156951-0").addService(googletag.pubads());}else if(Android_Msite == true || is_iOS_Mobile == true){console.log("m site"); var slot_9601 = googletag.defineSlot("/175434344/ETB-MDOT-ADP-English-National-International-300x250-1", [300, 250], "div-gpt-ad-9328143156951-0").addService(googletag.pubads());}else{console.log("Web"); var slot_9601=googletag.defineSlot("/175434344/ETB-ADP-English-National-International-728x90-1", [728, 90], "div-gpt-ad-9328143156951-0").addService(googletag.pubads());} googletag.pubads().enableSingleRequest();googletag.pubads().collapseEmptyDivs();googletag.enableServices(); googletag.display("div-gpt-ad-9328143156951-0");googletag.pubads().refresh([slot_9601]);googletag.pubads().setCentering(true); });
googletag.cmd.push(function() { googletag.display("div-gpt-ad-9328143156951-0");googletag.pubads().refresh(); });

The World Health Organisation (WHO) on Saturday named the new COVID-19 variant B.1.1.529, which has been detected in South Africa, as 'Omicron'.

This variant of COVID-19 was first reported to WHO from South Africa on Friday. The epidemiological situation in South Africa has been characterized by three distinct peaks in reported cases, the latest of which was predominantly the Delta variant, the WHO informed in a statement.

ANI

Next
Latest news direct to your inbox.